Preclinical imaging developer MILabs has signed an agreement to provide the Institute of Experimental Molecular Imaging at the Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen University with its high-resolution hybrid optical tomography/CT system.
The company's 3D/4D optical/CT system allows for quantitative deep-tissue imaging guided by high-contrast CT images at low radiation doses, MILabs said. The institute plans use the system to support research in the fields of nanomedicines and theranostics and its application for diagnosis and treatment of cancer and heart disease.
